Kazuyo Sasaki
9PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jul 11, 2025
Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan.Masaomi Nangaku, Kazuyo Sasaki, Jing Bi
|Mar 30, 2024
Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study.Akiko Takahashi, Manabu Ishii, Yurika Kino
|Mar 26, 2024
Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease: a post-hoc subgroup analysis of Japanese phase 3 randomized studies.Masaomi Nangaku, Kiichiro Ueta, Kenichi Nishimura
|Feb 09, 2022
Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan.Takashi Kadowaki, Nobuya Inagaki, Hirotaka Watada
|Dec 02, 2021
Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance.Nobuya Inagaki, Masaomi Nangaku, Yasushi Sakata
|Dec 25, 2019
Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan.Takashi Kadowaki, Masakazu Haneda, Hiroshi Ito
Pageof 2
